Published in Stroke on April 08, 2004
The pathobiology of vascular dementia. Neuron (2013) 3.07
Retinal vascular caliber, cardiovascular risk factors, and inflammation: the multi-ethnic study of atherosclerosis (MESA). Invest Ophthalmol Vis Sci (2006) 2.79
Hypertension: a harbinger of stroke and dementia. Hypertension (2013) 1.30
The eye and the heart. Eur Heart J (2013) 1.18
Hypertensive retinopathy revisited: some answers, more questions. Br J Ophthalmol (2005) 1.06
Flicker light-induced retinal vasodilation in diabetes and diabetic retinopathy. Diabetes Care (2009) 1.04
Openers of small conductance calcium-activated potassium channels selectively enhance NO-mediated bradykinin vasodilatation in porcine retinal arterioles. Br J Pharmacol (2010) 0.94
Divergent roles of nitric oxide and rho kinase in vasomotor regulation of human retinal arterioles. Invest Ophthalmol Vis Sci (2009) 0.94
Effects of saxagliptin on early microvascular changes in patients with type 2 diabetes. Cardiovasc Diabetol (2014) 0.91
Neurovascular regulation in the ischemic brain. Antioxid Redox Signal (2015) 0.89
The impact of age-related dysregulation of the angiotensin system on mitochondrial redox balance. Front Physiol (2014) 0.89
Dietary fiber intake and retinal vascular caliber in the Atherosclerosis Risk in Communities Study. Am J Clin Nutr (2007) 0.87
[Variance of retinal vessel diameter response to flicker light. A methodical clinical study]. Ophthalmologe (2006) 0.86
Pilot study for the evaluation of morphological and functional changes in retinal blood flow in patients with insulin resistance and/or type 2 diabetes mellitus. J Diabetes Sci Technol (2012) 0.80
Temporal development of retinal arteriolar endothelial dysfunction in porcine type 1 diabetes. Invest Ophthalmol Vis Sci (2012) 0.80
Retinal microperfusion after renal denervation in treatment-resistant hypertensive patients. Clin Res Cardiol (2015) 0.79
VEGF Receptor-2-Linked PI3K/Calpain/SIRT1 Activation Mediates Retinal Arteriolar Dilations to VEGF and Shear Stress. Invest Ophthalmol Vis Sci (2015) 0.77
Effects of bisoprolol and cilazapril on the central retinal artery blood flow in patients with essential hypertension--preliminary results. Ups J Med Sci (2010) 0.77
Intake of dietary salt and drinking water: Implications for the development of age-related macular degeneration. Mol Vis (2016) 0.76
Acute and Chronic Hyperglycemia Elicit JIP1/JNK-Mediated Endothelial Vasodilator Dysfunction of Retinal Arterioles. Invest Ophthalmol Vis Sci (2016) 0.75
Relationship of Hypertensive Retinopathy with Mean Platelet Volume Among Hypertensive Patients. Cureus (2015) 0.75
Retinal Capillary Rarefaction in Patients with Type 2 Diabetes Mellitus. PLoS One (2016) 0.75
Effectiveness of in-office blood pressure measurement by eye care practitioners in early detection and management of hypertension. Int J Ophthalmol (2015) 0.75
Retinal Microcirculation in Type 1 Diabetic Patients With and Without Peripheral Sensory Neuropathy. J Diabetes Sci Technol (2014) 0.75
2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens (2007) 20.09
2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens (2013) 18.17
Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet (2010) 14.40
Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial. Lancet (2008) 13.34
Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N Engl J Med (2009) 12.73
2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J (2013) 12.73
2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J (2007) 9.43
Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens (2009) 4.87
Urinary sodium and potassium excretion and risk of cardiovascular events. JAMA (2011) 4.68
2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. J Hypertens (2007) 4.59
Macrophages regulate salt-dependent volume and blood pressure by a vascular endothelial growth factor-C-dependent buffering mechanism. Nat Med (2009) 4.07
Renin-angiotensin system and cardiovascular risk. Lancet (2007) 3.47
Ambulatory blood pressure changes after renal sympathetic denervation in patients with resistant hypertension. Circulation (2013) 3.44
2013 ESH/ESC Practice Guidelines for the Management of Arterial Hypertension. Blood Press (2013) 2.62
Rapid nongenomic effects of aldosterone on human forearm vasculature. Hypertension (2003) 2.34
Renal sympathetic denervation for treatment of drug-resistant hypertension: one-year results from the Symplicity HTN-2 randomized, controlled trial. Circulation (2012) 2.07
Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. Blood Press (2009) 1.98
Impact of new-onset diabetes mellitus on development of atrial fibrillation and heart failure in high-risk hypertension (from the VALUE Trial). Am J Cardiol (2008) 1.92
Aliskiren, a novel orally effective renin inhibitor, provides dose-dependent antihypertensive efficacy and placebo-like tolerability in hypertensive patients. Circulation (2005) 1.89
Rosuvastatin in diabetic hemodialysis patients. J Am Soc Nephrol (2011) 1.85
Effect of telmisartan on renal outcomes: a randomized trial. Ann Intern Med (2009) 1.85
A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension. Am J Med (2003) 1.83
Inhibition of prolyl hydroxylases increases erythropoietin production in ESRD. J Am Soc Nephrol (2010) 1.77
Prevention of atrial fibrillation by Renin-Angiotensin system inhibition a meta-analysis. J Am Coll Cardiol (2010) 1.70
Analysis of NO-synthase expression and clinical risk factors in human diabetic nephropathy. Nephrol Dial Transplant (2007) 1.66
Renal and cardiac effects of antihypertensive treatment with ramipril vs metoprolol in autosomal dominant polycystic kidney disease. Nephrol Dial Transplant (2007) 1.65
AT1-receptor blockade improves augmentation index: a double-blind, randomized, controlled study. J Hypertens (2002) 1.63
Hypertension induces somatic cellular senescence in rats and humans by induction of cell cycle inhibitor p16INK4a. Hypertension (2008) 1.63
Basal nitric oxide activity is an independent determinant of arteriolar structure in the human retinal circulation. J Hypertens (2011) 1.53
Detection of angiotensin II in supernatants of stimulated mononuclear leukocytes by matrix-assisted laser desorption ionization time-of-flight/time-of-flight mass analysis. Hypertension (2005) 1.52
Renal denervation in moderate treatment-resistant hypertension. J Am Coll Cardiol (2013) 1.52
Effects of statin treatment on endothelial function, oxidative stress and inflammation in patients with arterial hypertension and normal cholesterol levels. J Hypertens (2011) 1.51
Rapid nongenomic effects of aldosterone on the renal vasculature in humans. Hypertension (2006) 1.51
23Na magnetic resonance imaging-determined tissue sodium in healthy subjects and hypertensive patients. Hypertension (2013) 1.51
Remodeling of retinal small arteries in hypertension. Am J Hypertens (2011) 1.50
Dynamic expression patterns of transforming growth factor-beta(2) and transforming growth factor-beta receptors in experimental glomerulonephritis. J Mol Med (Berl) (2002) 1.49
Serum levels of the Th1 chemoattractant interferon-gamma-inducible protein (IP) 10 are elevated in patients with essential hypertension. Hypertens Res (2011) 1.49
Hypertension, sodium retention, calcium excretion and osteopenia in Dahl rats. J Hypertens (2004) 1.48
Urinary proteomic biomarkers in coronary artery disease. Mol Cell Proteomics (2007) 1.47
Renal injury in streptozotocin-diabetic Ren2-transgenic rats is mainly dependent on hypertension, not on diabetes. Am J Physiol Renal Physiol (2006) 1.47
Retracted Changes of radial diffusivity and fractional anisotropy in the optic nerve and optic radiation of glaucoma patients. ScientificWorldJournal (2012) 1.46
The role of nitric oxide in the regulation of glomerular haemodynamics in humans. Nephrol Dial Transplant (2004) 1.46
Direct comparison of the effects of valsartan and amlodipine on renal hemodynamics in human essential hypertension. Am J Hypertens (2003) 1.45
Renal vascular endothelial function in hypertensive patients with type 2 diabetes mellitus. Am J Kidney Dis (2008) 1.44
Intrauterine growth restriction leads to a dysregulation of Wilms' tumour supressor gene 1 (WT1) and to early podocyte alterations. Nephrol Dial Transplant (2012) 1.44
New software analyses increase the reliability of measurements of retinal arterioles morphology by scanning laser Doppler flowmetry in humans. J Hypertens (2011) 1.44
Elevation of sympathetic activity by eprosartan in young male subjects. Am J Hypertens (2003) 1.42
Effect of the angiotensinogen genotype on experimental hypertension in mice. J Mol Med (Berl) (2007) 1.41
Effects of enalapril and eprosartan on the renal vascular nitric oxide system in human essential hypertension. Kidney Int (2002) 1.41
Fourier analysis of the envelope of the ophthalmic artery blood flow velocity: age- and blood pressure related impact. Hypertension (2007) 1.41
Impact of NO-synthase inhibition on renal hemodynamics in normotensive and hypertensive subjects. J Hypertens (2002) 1.41
Folic acid treatment normalizes NOS-dependence of vascular tone in the metabolic syndrome. Obesity (Silver Spring) (2010) 1.40
Haemoglobin and vascular function in the human retinal vascular bed. J Hypertens (2013) 1.39
Effect of aliskiren on vascular remodelling in small retinal circulation. J Hypertens (2015) 1.39
Hypercholesterolaemia and treatment with statins do not alter L-arginine-induced changes of renal haemodynamics. Nephrol Dial Transplant (2002) 1.39
Role of the angiotensin II type 2 receptor gene (+1675G/A) polymorphism on left ventricular hypertrophy and geometry in treated hypertensive patients. J Hypertens (2010) 1.39
High sodium intake modulates left ventricular mass in patients with G expression of +1675 G/A angiotensin II receptor type 2 gene. J Hypertens (2007) 1.37
Olmesartan improves pulse wave velocity and lowers central systolic blood pressure and ambulatory blood pressure in patients with metabolic syndrome. J Clin Hypertens (Greenwich) (2014) 1.37
Joint statement of the European Association for the Study of Obesity and the European Society of Hypertension: obesity and difficult to treat arterial hypertension. J Hypertens (2012) 1.37
Aliskiren, an orally effective renin inhibitor, provides antihypertensive efficacy alone and in combination with valsartan. Am J Hypertens (2007) 1.36
Glycosaminoglycan polymerization may enable osmotically inactive Na+ storage in the skin. Am J Physiol Heart Circ Physiol (2004) 1.36
Osmotically inactive skin Na+ storage in rats. Am J Physiol Renal Physiol (2003) 1.36
Increased wall:lumen ratio of retinal arterioles in male patients with a history of a cerebrovascular event. Hypertension (2007) 1.33
(23)Na magnetic resonance imaging of tissue sodium. Hypertension (2011) 1.29
(Pro)renin receptor peptide inhibitor "handle-region" peptide does not affect hypertensive nephrosclerosis in Goldblatt rats. Hypertension (2008) 1.27
Strain differences in the development of hypertension and glomerular lesions induced by deoxycorticosterone acetate salt in mice. Nephrol Dial Transplant (2003) 1.25
Beyond salt: lifestyle modifications and blood pressure. Eur Heart J (2011) 1.24
Lipid-independent effects of statins on endothelial function and bioavailability of nitric oxide in hypercholesterolemic patients. Am Heart J (2005) 1.22
Salt and hypertension: is salt dietary reduction worth the effort? Am J Med (2012) 1.22
Angiotensin converting enzyme inhibition and angiotensin II AT1-receptor blockade reduce the levels of asymmetrical N(G), N(G)-dimethylarginine in human essential hypertension. Am J Hypertens (2002) 1.19
Mobilization of osmotically inactive Na+ by growth and by dietary salt restriction in rats. Am J Physiol Renal Physiol (2007) 1.17
Glaucoma risk index: automated glaucoma detection from color fundus images. Med Image Anal (2010) 1.17
Wall-to-lumen ratio of retinal arterioles is related with urinary albumin excretion and altered vascular reactivity to infusion of the nitric oxide synthase inhibitor N-monomethyl-L-arginine. J Hypertens (2009) 1.13
Internal sodium balance in DOCA-salt rats: a body composition study. Am J Physiol Renal Physiol (2005) 1.13
Effect of irbesartan versus atenolol on left ventricular mass and voltage: results of the CardioVascular Irbesartan Project. Hypertension (2004) 1.11
Left ventricular hypertrophy and clinical outcomes in hypertensive patients. Am J Hypertens (2008) 1.10
Urinary proteomic diagnosis of coronary artery disease: identification and clinical validation in 623 individuals. J Hypertens (2010) 1.09
The German Chronic Kidney Disease (GCKD) study: design and methods. Nephrol Dial Transplant (2011) 1.09
Enhanced levels of platelet P-selectin and circulating cytokines in young patients with mild arterial hypertension. J Hypertens (2005) 1.08
Analysis of retinal arteriolar structure in never-treated patients with essential hypertension. J Hypertens (2008) 1.08
Measurement of kidney perfusion by magnetic resonance imaging: comparison of MRI with arterial spin labeling to para-aminohippuric acid plasma clearance in male subjects with metabolic syndrome. Nephrol Dial Transplant (2009) 1.07
Role of asymmetric dimethylarginine for angiotensin II-induced target organ damage in mice. Am J Physiol Heart Circ Physiol (2007) 1.07